EUVIMEDEUVIMED entdecken
Crossref

Radiotherapy-induced TACC3 confers resistance of HCC to radiotherapy and enhances IL4-dependent immunosuppression to exacerbate hepatocarcinogenesis

Cheng-Rui Zhong, Zong-Feng Wu, Zi-Qi Zheng, Zhu Lin, Yong-Ling Liang, Ze-Jin Lin, Yun-Le Wan, Guo-Lin Li

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Cheng-Rui Zhong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Hepatobiliary Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 51065…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Radiation Tolerance, Interleukin-4. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy plays an increasingly crucial role in the treatment of hepatocellular carcinoma (HCC). However, resistance to radiotherapy remains a significant obstacle to achieving optimal treatment outcomes. Our objective is to elucidate the mechanisms underlying radiotherapy resistance. Through proteomic sequencing of radiotherapy-resistant cell lines and patient-derived xenograft tissues from HCC patients, we identified that Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) is upregulated in both radiotherapy-resistant cell lines and tissues. After radiotherapy treatment, DNAPK phosphorylates TACC3 at 315 threonine, leading to enhanced protein stability of TACC3. TACC3 facilitated the proliferative capacity and radiotherapy resistance of HCC cells by promoting the interaction between XRCC5 and XRCC6 through specific residues within its coiled-coil domain, namely ILE736, ASN742 and GLU773. This interaction facilitates DNA damage repair via the non-homologous end joining pathway in response to radiation, thereby contributing to the radiotherapy resistance in HCC cells. Furthermore, TACC3 increases the production of IL-4 and IL-10 within HCC cells, inducing the differentiation of M0 macrophages to M2 macrophages within the immune microenvironment, leading to the suppression of CD8+T cell cytotoxic functions and creating an immunosuppressive microenvironment in HCC. Targeting TACC3 with inhibitor KHS101 significantly inhibit the proliferation of HCC and improve the immune microenvironment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRadiation ToleranceInterleukin-4HumansAnimalsMiceTumor MicroenvironmentCell Line, TumorCell ProliferationXenograft Model Antitumor AssaysMacrophagesGene Expression Regulation, NeoplasticDNA-Binding ProteinsMicrotubule-Associated Proteins

Stichwörter der Autor:innen

HCCMacrophageTACC3XRCC5/6radiotherapy resistance

Substanzen

TACC3 protein, humanInterleukin-4DNA-Binding ProteinsMicrotubule-Associated Proteins

Autor:innen und Institutionen

  • Department of General Surgery (Hepatobiliary Pancreatic and Splenic Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China; Biomedical Innovation Center, The Sixth Affiliated Hospital,…
  • Department of Liver Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Univers…
  • Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Unive…

Zitieren

APA

Zhong, C. R., Wu, Z. F., Zheng, Z. Q., Lin, Z., Liang, Y. L., Lin, Z. J., Wan, Y. L., & Li, G. L. (2025). Radiotherapy-induced TACC3 confers resistance of HCC to radiotherapy and enhances IL4-dependent immunosuppression to exacerbate hepatocarcinogenesis. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217819

Vancouver

Zhong CR, Wu ZF, Zheng ZQ, Lin Z, Liang YL, Lin ZJ, et al. Radiotherapy-induced TACC3 confers resistance of HCC to radiotherapy and enhances IL4-dependent immunosuppression to exacerbate hepatocarcinogenesis. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217819

BibTeX
@article{Zhong2025,
  author = {Zhong, Cheng-Rui and Wu, Zong-Feng and Zheng, Zi-Qi and Lin, Zhu and Liang, Yong-Ling and Lin, Ze-Jin and Wan, Yun-Le and Li, Guo-Lin},
  title = {Radiotherapy-induced TACC3 confers resistance of HCC to radiotherapy and enhances IL4-dependent immunosuppression to exacerbate hepatocarcinogenesis},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217819}
}
Kostenlos starten →